276 related articles for article (PubMed ID: 12672201)
1. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
Solomon DH; Glynn RJ; Bohn R; Levin R; Avorn J
J Rheumatol; 2003 Apr; 30(4):792-8. PubMed ID: 12672201
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population.
Rahme E; Joseph L; Kong SX; Watson DJ; LeLorier J
Arthritis Rheum; 2000 Apr; 43(4):917-24. PubMed ID: 10765939
[TBL] [Abstract][Full Text] [Related]
3. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
[TBL] [Abstract][Full Text] [Related]
5. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
6. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
7. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
Spiegel BM; Chiou CF; Ofman JJ
Arthritis Rheum; 2005 Apr; 53(2):185-97. PubMed ID: 15818647
[TBL] [Abstract][Full Text] [Related]
8. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
10. Predicting the risk of gastrointestinal bleeding due to nonsteroidal antiinflammatory drugs: NSAID electronic assessment of risk.
Cheetham TC; Levy G; Spence M
J Rheumatol; 2003 Oct; 30(10):2241-4. PubMed ID: 14528523
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.
Shireman TI; Rigler SK
Am J Geriatr Pharmacother; 2006 Sep; 4(3):210-8. PubMed ID: 17062321
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
13. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
14. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
Hur C; Chan AT; Tramontano AC; Gazelle GS
Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
Blomqvist P; Feltelius N; Ekbom A; Klareskog L
J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
Tannenbaum H; Bombardier C; Davis P; Russell AS;
J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
[TBL] [Abstract][Full Text] [Related]
17. New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study.
Wang J; Mullins CD; Mamdani M; Rublee DA; Shaya FT
Ann Pharmacother; 2007 Jun; 41(6):937-43. PubMed ID: 17488830
[TBL] [Abstract][Full Text] [Related]
18. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
[TBL] [Abstract][Full Text] [Related]
19. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).
Cox ER; Motheral B; Mager D
Am J Manag Care; 2003 Dec; 9(12):785-94. PubMed ID: 14712755
[TBL] [Abstract][Full Text] [Related]
20. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.
Mosis G; Stijnen T; Castellsague J; Dieleman JP; van der Lei J; Stricker BH; Sturkenboom MC
Arthritis Rheum; 2006 Aug; 55(4):537-42. PubMed ID: 16874797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
